Tracy M. Downs, MD, FACS Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Downs is a urologic surgeon and fellowship-trained specialist in urologic oncology. He performs specialized surgery for complex cancers of the genitourinary tract, including robotic cystectomy and other minimally invasive procedures. He has a special interest in the treatment of bladder cancer, and directs the UW Bladder Cancer and Intravescial Therapy Programs.
UW School of Medicine and Public Health
|Department of Urology|
Professional Certifications and Education
Urologic Oncology, University of California-San Francisco, San Francisco, CA, 2003
Brigham and Women's Hospital, Boston, MA
University of California, San Diego School of Medicine, La Jolla, CA, 1993
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Downs has a joint appointment with the UW Carbone Cancer Center where his translational research focuses on discovery of molecular and urinary biomarkers for bladder cancer and his clinical research focuses on developing new therapies for genitourinary cancers.
Tazeh N Scott K Damodaran S Huang W Downs T .
Chondroma of the Bladder: A Case Report and Review of the Literature. Urology. 2017 May 4;
[PubMed ID: 28479478]
Blute ML Jr Kucherov V Rushmer TJ Damodaran S Shi F Jason Abel E Jarrard DF Richards KA Messing EM Downs TM .
Reduced Estimated Glomerular Filtration Rate (eGFR <60 ml/min) at First Transurethral Resection of Bladder Tumor is a Significant Predictor of Subsequent Recurrence and Progression. BJU Int. 2017 May 2;
[PubMed ID: 28464520]
Gee JR Saltzstein DR Kim K Kolesar J Huang W Havighurst TC Wollmer BW Stublaski J Downs T Mukhtar H House MG Parnes HL Bailey HH .
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers. Cancer Prev Res (Phila). 2017 May;10(5):298-307
[PubMed ID: 28325826]
Tazeh NN Canter DJ Damodaran S Rushmer T Richards KA Abel EJ Jarrard DF Downs TM .
Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences. Bladder Cancer. 2017 Apr 27;3(2):89-94
[PubMed ID: 28516153]
Ravvaz K Walz ME Weissert JA Downs TM .
Predicting non-muscle invasive bladder cancer recurrence and progression in a US population. J Urol. 2017 Apr 19;
[PubMed ID: 28433642]
Tobert CM Hamilton-Reeves JM Norian LA Hung C Brooks NA Holzbeierlein JM Downs TM Robertson DP Grossman R Nepple KG .
The Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications on Cystectomy for Bladder Cancer. J Urol. 2017 Mar 9;
[PubMed ID: 28286066]
Lane GI Downs TM Soubra A Rao A Hemsley L Laylan C Shi F Konety B .
Tolerability of Repeat Use of Blue Light Cystoscopy with Hexaminolevulinate for Patients with Urothelial Cell Carcinoma. J Urol. 2017 Mar;197(3 Pt 1):596-601
[PubMed ID: 27664580]
Blute ML Jr Damaschke N Wagner J Yang B Gleave M Fazli L Shi F Abel EJ Downs TM Huang W Jarrard DF .
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy. PLoS One. 2017;12(2):e0172048
[PubMed ID: 28234906]
Blute ML Jr Ziemlewicz TJ Lang JM Kyriakopoulos C Jarrard DF Downs TM Grimes M Shi F Mann MA Abel EJ .
Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric Analysis. Urology. 2017 Feb;100:139-144
[PubMed ID: 27667156]
Grimes MD Blute ML Jr Wittmann TA Mann MA Zorn K Downs TM Shi F Jarrard DF Best SL Richards KA Nakada SY Abel EJ .
A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery. Urology. 2016 Oct;96:93-98
[PubMed ID: 27339026]
Jarrard D Konety B Huang W Downs T Kolesar J Kim KM Havighurst T Slaton J House MG Parnes HL Bailey HH .
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy. Am J Clin Exp Urol. 2016;4(2):17-27
[PubMed ID: 27766277]
Blute ML Jr Zorn K Grimes M Shi F Downs TM Jarrard DF Best SL Richards K Nakada SY Abel EJ .
Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer. BJU Int. 2016 Sep;118(3):399-407
[PubMed ID: 26589741]
Downs TM .
Editorial Comment. J Urol. 2016 Feb;195(2):412
[PubMed ID: 26592567]
Blute ML Jr Rushmer TJ Shi F Fuller BJ Abel EJ Jarrard DF Downs TM .
Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer. J Urol. 2015 Nov;194(5):1214-9
[PubMed ID: 26173101]
Abel EJ Heckman JE Hinshaw L Best S Lubner M Jarrard DF Downs TM Nakada SY Lee FT Jr Huang W Ziemlewicz T .
Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses. J Urol. 2015 Oct;194(4):886-91
[PubMed ID: 25837535]
Blute ML Jr Abel EJ Downs TM Kelcz F Jarrard DF .
Addressing the need for repeat prostate biopsy: new technology and approaches. Nat Rev Urol. 2015 Aug;12(8):435-44
[PubMed ID: 26171803]
Potretzke AM Wong KS Shi F Christensen W Downs TM Abel EJ .
Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers. Urol Ann. 2015 Jul-Sep;7(3):355-60
[PubMed ID: 26229325]
Downs TM .
Reducing readmissions and mortality after radical cystectomy. J Urol. 2015 May;193(5):1461-2
[PubMed ID: 25711198]
Downs T .
Editorial comment. J Urol. 2015 Feb;193(2):450
[PubMed ID: 25534588]
Abel EJ Linder BJ Bauman TM Bauer RM Thompson RH Thapa P Devon ON Tarrell RF Frank I Jarrard DF Downs TM Boorjian SA .
Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol. 2014 Dec;66(6):1139-47
[PubMed ID: 25194909]